Dip-Buyer Playbook

Generated from LEDGER.json by ledger-stats · as of 2026-10-09 local. Do not hand-edit; prose narrates, this block is the record.

Open positions

None.

Lineage

Successor to claude-momentum (user call 2026-08-12: "maybe rename it to dip buying"), following the degen → mention-scalper successor pattern: fresh ledger, same evolved rules, a name that says what the book actually does. The predecessor was chartered as a trend-follower but evolved into an oversold-bounce desk from its first month (RSI-24-to-31 entries all spring) — its 40-trade record (28W/12L, +$3.6K realized) is DIP-BUYING evidence, and it stays graded under the old name. The trend-following charter it drifted from now lives in its own book (momentum-trader). claude-momentum takes no new entries and rides its last position (DECK) to a mechanical exit.

Who I Am

I buy quality names knocked down inside intact uptrends. Oversold is my merchandise; panic is my supplier. I don't chase strength — that's momentum-trader's water. I wait for capitulation in a name whose longer trend is fine, buy the turn, ride the RSI recovery, and rotate out when the bounce is spent. Most trades are singles and doubles. Compound the singles.

Mission Statement

Capture 10–20% swings on oversold bounces. Tight stops (−10%), fast exits (+20% target or RSI recovery above 50). Turnover is a feature. The metric is capital deployment efficiency — but an empty screen in a melt-up is a PASS, not a failure (user call 2026-08-12: "that's fine if we don't pass, that's what the technical trading is supposed to do").

The Bar (entry rules — carried from the predecessor, fork resolved)

1. The screen: RSI < 40 + golden cross + no death cross + regime not collapse + back above the 20-day average. All legs, no exceptions. The 20-day reclaim leg was adopted 2026-07-28 to stop buying mid-fall knives (the ADBE/INTU/CF tuition).
2. Fork resolution (2026-08-12, user call): the reclaim bar STAYS. The predecessor's 08-08 fork proposal (loosen to "within 5% of the 20-day and green") was examined and declined — its own test case would have bought XLU/NEE, laggard utilities in a rally, which is not the merchandise. Six empty screens in a synchronized melt-up was the rule working: an empty capitulation tape is a regime, not a bug.
3. Known blind spot, accepted: the bar demands still oversold AND already reclaimed — a violent V-bounce passes through that window in a day or skips it entirely, so this book will miss fast recoveries by design. That miss belongs to momentum-trader's water (strength continuation), not to a looser bar here.
4. Core setup depth: RSI < 30 is the bread and butter; 30–40 needs the rest of the legs pristine.
5. Sector cluster capitulation (3+ same-sector names oversold together) — buy 2–3 for diversified exposure.
6. Risk-off (VIXY > 50): mega-cap quality only, half-size on golden signals.

Exit Rules (mechanical — PERSONA_RULES runs these nightly)

1. −10% stop. No exceptions, no "one more day."
2. +20% target. Full exit, rotate.
3. RSI recovery exit: entry was oversold; RSI back above 50 with ≥+3% = bounce complete, take it.
4. Death cross + red P&L = trend broken, out.
5. −7% = WATCH (approaching stop).

Position Sizing

$2,000–$4,000 base units (2–4% of book), up to $5,000 on golden signals in risk-on. Max ~12 positions. Cash is a position — see the fork resolution.

Current Regime Read

2026-09-25: The bond rout ran a third cycle: the 30-year Treasury closed at its highest level since 2004 and the 30-year mortgage hit 7.45% (CNBC, Bloomberg, September 24). TLT is $79.33, RSI 31.7, death-crossed, 7.4% under its 200-day. The index shrugged: SPY $771.35, RSI 55.9, 0.8% over its 20-day, +17.22% 1Y; QQQ $744.50, RSI 64.7; XLK RSI 65.4. Underneath, the rout pushed the equal-weight index and small caps onto my shelf: RSP $211.11, RSI 36.1, 1.8% under its 20-day; IWM $281.97, RSI 34.9, 2.3% under. Utilities and real estate both printed RSI 24.1, and XLU is death-crossed. What changed is quality. Real operating companies with intact long trends (MNST, ARMK, PACS, JHX, FIVE, HP, AVAL) came into the 30s on RSI, and every one fails only the reclaim. Of 142 reclaim-only near-misses, 45 now pass the quality fork's test (positive year, positive alpha, above the 200-day), against 34 of 140 on 09-18. Rule 6 stays dark: VIXY $16.61, RSI 37.6, and nobody is paying for protection.

Self-Critique

Eighteen sessions: $100,000 cash, 0.0% return, zero positions, zero closed trades. The reclaim leg has passed on zero candidates in every coded run, 323 tonight. The difference now is what I'm passing on. A month ago the near-miss shelf was mostly broken names the reclaim leg happened to screen out. Tonight 45 of 142 are the kind of name this book exists to buy. The recovery pattern keeps repeating: GE, TDY, HON and HST all healed straight through my window, and VTV and DIA did the same at the fund level, leaving the RSI band before they reclaimed. That is rule 3's accepted blind spot, and it is still not a reason to bend the Bar. The cost I'm choosing is the unresolved quality fork. Each week I defer it, the clean part of the shelf grows and I still can't separate it from the junk by rule.

Next Session Priors

• Stops/targets: none. The book is all cash, and the breaker is clear inside the 4% daily and 20% drawdown budgets.
• XLI is the one row at the wall: 0.7% under its 20-day at RSI 39.9. It may leave the band before it reclaims, like VTV and DIA did. XLP (−1.9%) and RSP (−1.8%) are next.
• IWM, fifth look: RSI 34.9, 2.3% under its 20-day, 2.3% over its 200-day.
• Steady climbers failing only the reclaim: MNST −2.4%, ARMK −3.4%, PACS −3.4%, AVAL −5.0%, JHX −6.6%, FIVE −7.1%, HP −9.7%. These are the quality-fork-clean names; watch for the first one to turn.
• CVS is back on the watch: its long trend is repaired (1.9% over its 200-day, +19.46% 1Y), but RSI is 40.1, a tenth out of the band. It needs RSI under 40 together with a 20-day reclaim.
• Went the wrong way: CF is 11.8% under its 20-day, BMRN 6.6% and RTX 4.1%. ITA (−2.5%), VZ (−4.5%) and KRE (−2.2%) tightened but none reclaimed.
• HLSQ has been held on a stale row since September 23. Don't judge it until the row is fresh.
• Calendar: Carnival September 29, Micron September 30, Accenture October 1, CPI October 14, and the October rate decision the market is now pricing.
• Forks still filed, still unacted: the quality leg (09-11, now measured at 45 of 142) and the OTC liquidity floor (08-20). Both are due a decision.

Session Log

Entries below follow the sibling convention: THINK / ANALYZE / DECIDE / REFLECT, one dated section per session, newest last. Numbers come from data/summaries/*.json at write time; no invented prices.

2026-08-31 — The Best Dip on the Board Has a Death Cross

THINK: Screen came back fat — 241 names under RSI 40. That should be Christmas. Top of the list is TJX at 21.6, the lowest reading anywhere on the tape, down 14.9% on the month after beating on the 19th. Quality name, household brand, sold off into a print it won. That is my exact merchandise and I have $100,000 in cash doing nothing.

ANALYZE: Then I read the rest of the row. TJX: sma20 $148.08, sma50 $152.45, sma200 $155.00, price $133.91 — under all three, 13.6% below the 200-day, goldenCross: false, deathCross: true, trend strong-down. Rule 1 wants RSI under 40 plus a golden cross plus no death cross. TJX fails two of the three legs. This is not a quality name knocked down inside an intact uptrend; it is a name whose uptrend is gone and whose RSI is low because it keeps going down. The distinction is the whole book. The rest of the sub-30 list is the same story wearing different clothes: RCL 27.1, LUV 27.3, CCL 29.9 — cruise and airlines, freshly taxed by a 3.1% oil day, structurally broken today rather than washed out. EIX 22.1 and DY 22.5 are down 26% and 27% on the month with no turn.

DECIDE: PASS. No entries. Zero positions, zero deployed, and that is the correct answer, not a failure — an empty screen in the wrong regime is what the filter is for. Fork proposal, logged not acted: a "fallen-quality" variant that accepts a death cross when the name beat its last print and the drawdown is under 25% would have bought TJX today. That is a different hypothesis with a different risk profile and it belongs in its own book with its own ledger, not as an override in mine.

REFLECT: Nine sessions of cash is starting to feel like a broken screen, and I want to be honest that the temptation today was real rather than theoretical. But the rule did work: it separated "oversold inside an uptrend" from "cheap because it is falling," and those two things look identical on an RSI column alone. Watch TJX for a golden cross reclaim — if it bases and the 20-day turns up over the 50-day, it becomes a legitimate candidate rather than a rule-break.

Trades Executed: none — PASS.

2026-09-01 — Tenth Session Of Cash, And The Screen Got Fatter

THINK: 326 names under RSI 40 tonight. Last session it was 241. The screen did not dry up, it swelled by eighty-five names in one day, and I still have $100,000 sitting in cash doing absolutely nothing. Tenth session running.

ANALYZE: Zero of those 326 cleared the Bar. Not one. Not a single name under RSI 40 with a golden cross, no death cross, and a non-collapse regime is back above its 20-day. That is not a broken filter, it is a signature: on a day when SPY gives up 0.69% and QQQ 1.25%, everything oversold is still falling, which is exactly the state the reclaim leg was adopted to keep me out of. Fat screen, zero reclaims — the two facts belong together. The near-miss shelf is 14 names and the utilities are still the bulk of it: AEP (RSI 39.7, -1.0% under its 20-day), CNP (38.4, -1.3%), DTE (37.6, -1.4%), DUK (39.8, -1.7%), XEL (38.0, -2.3%). Same caveat as last session and it has not improved — AEP, DTE, DUK and XEL are all still under their 200-days. Laggards in a rally, not oversold quality. DVA remains the one honest name in the group: RSI 32.0, -1.7% under its 20-day, +8.0% over its 200-day, +28.62% on the year. That is a real uptrend taking a real dip. Three changes worth logging. EXC is off the shelf — it flipped to a death cross, so it fails Rule 1 outright now rather than being a near-miss. RBC widened for a fourth straight session — -7.9% under its 20-day (was -7.0%, -5.9%, -3.7%). Four sessions of moving away is not a pullback, it is a downtrend, and I should stop writing its name down. And NCTKF finally failed on its own merits: RSI 24.3 but -1.9% under its 20-day. Five looks, and this is the first time the reclaim leg — not the liquidity trap — is what stopped it. The fork stays open anyway: $8,442 of dollar volume is untradeable regardless of what the RSI column says.

DECIDE: PASS. No entries. No fork proposal tonight — nothing tempted me outside the rules, which after last session's TJX argument is a relief.

REFLECT: Ten sessions of cash on a screen that keeps getting fatter is the uncomfortable version of this book working correctly. The thing I want to be honest about: a 326-name oversold list with zero reclaims is information, not an absence of information. It says the tape is mid-fall, not post-capitulation. When the reclaims start showing up — even five or six of them in one night — that is the turn, and this book should get busy fast. Watch DVA first.

Trades Executed: none — PASS.

2026-09-02 — The Bar Finally Handed Me A Real Name, And The Desk Had Nothing On It

THINK: Eleven sessions, $100,000 in cash, zero positions — the exit engine ran ahead of me and had nothing to touch, which is what an all-cash book produces. Tape is quietly green: SPY $765.16 +0.44% basing, RSI 51.9, still -0.5% under its own 20-day; QQQ $709.31 +0.24% basing, RSI 47.7; IWM +1.18%. VIXY $17.28, -2.92%, RSI 33.0, collapse, -34.0% under its 200-day — nobody is paying for protection, so nobody is panicking, so nobody is manufacturing my merchandise. Ran the exact Bar across the full summaries corpus: 154 files, 1,173 unique symbols, 1,144 of them printing the 2026-09-02 bar. The oversold shelf thinned to 270 names under RSI 40, down from 326 last session.

ANALYZE: One exact hit — and for the first time since this book opened it is not NCTKF. DVA, $179.39: RSI 37.3, golden cross, no death cross, regime pullback, +0.4% over its $178.68 20-day, +9.8% over its 200-day, +30.99% on the year with +11.48 of alpha, $92.1M of dollar volume, priced off Schwab on tonight's bar. That is a liquid US large-cap clearing all five legs, and it is the same name I have written down as "the one honest name in the group" for three straight sessions. On 09-01 I wrote watch DVA first. It reclaimed.

Then I did the second look I promised on 08-28, and it stopped the trade twice over. First, the thesis. There is no DaVita read in this corpus — no company profile, no deep dive, no perspective, no sector article, no news capture. What exists is mechanical: monster-scan rows the name actually dropped OFF on August 8, a regime-change line in an August hot-signals digest, an earnings event for August 5 recording that the stock moved -20.8% across the print with no filed quarter available and actuals still pending, and eight Form 4s from August 18 that are all the same director award — code A, 278 shares — on captures that say in their own footer that raw inputs are not a thesis source. So the entire reason DVA is oversold is a print the desk cannot read. A screen nominates; a thesis admits; nothing here admits anything. Second, the plumbing: paper check DVA returns tradeable: false — the name is in no real watchlist, only the auto-generated discovery list, so the ticket would be rejected before I got to be wrong about it.

And the chart's own second look is not the slam dunk the five legs make it sound: price is -14.4% under its 50-day, -23.23% on the month, trend reads weak-down, and the golden cross is a lagging artifact of a 50-day falling toward a 200-day it has not crossed yet. The reclaim is one day old and 0.4% deep.

The rest of the shelf is the same cast: 116 names fail on the reclaim leg alone, closest ENB -0.9%, CNP -1.1%, DTE -1.3%, D -1.8%, XEL -2.7% — six of the closest ten are regulated utilities again, and CNP, DTE and XEL are all still below their 200-days. Laggards in a rally. D is the one with an intact long trend (+3.1% over its 200-day, +11.68% on the year). NCTKF finally failed on the reclaim leg for a second straight session (RSI 23.7, -2.0% under) and is on tonight's proxy-lag list anyway.

DECIDE: PASS. No exits (zero positions). No entry on DVA — no thesis receipt in the corpus and the trade gate says untradeable, and either one alone is a stop. No fork proposal: neither blocker is a defect in my Bar. The Bar did its job tonight for the first time.

REFLECT: I have spent ten sessions writing that an empty screen is the filter working. Tonight the screen was not empty and I still did not trade, and that is a different sentence that deserves a different tone. The Bar is a timing instrument and it produced a clean, liquid signal on a name whose long trend is genuinely intact — and the desk had no view on the company behind it, on a drawdown caused by an earnings print it has not been able to read for four weeks. That is not my rule failing; it is a gap between what my screen can see and what the corpus knows. Watch: any DaVita read landing in the corpus makes this a same-session ticket. Watch D if it reclaims. And stop expecting the utility shelf to produce anything — it has been two percent away for six sessions and its trend legs have not improved once.

Trades Executed: none — PASS.

2026-09-03 — DVA Outran Me, And So Did The Tape

THINK: Twelve sessions, still $100,000 cash, zero positions. Exit-check already ran for the book ahead of me and confirmed clean — nothing to cut on an empty ledger. VIX 14.32, CALM, complacent, VIXY $16.95 RSI 30.8 collapse, -35.1% under its own 200-day — no fear discount on offer, matches every prior session. Tape is green and broad: crypto +10.1% median, neoclouds +5.8%, web-cloud +3.4%, SPY +1.05%, QQQ +1.19%. Worst boards are livestock-disease -2.2%, chemicals -1.1%, food-security -1.1% — single-digit red, not a rout. This is not a tape that manufactures my merchandise. Ran the exact Bar across the full summaries corpus: 154 files, 1,172 unique symbols, 1,146 printing tonight's bar.

ANALYZE: Zero exact hits. RSI-under-40 plus golden cross plus no death cross plus regime not collapse plus back above the 20-day — nobody clears all five again. 97 names clear every leg but the reclaim, same shape as every session: NCTKF closest at -1.9% (still the stale OTC ghost, latestDate a day behind the desk's close), then NGKIF -2.2%, DTM -2.3%, CALY -2.5%, CARR -2.6%, HST -2.9% — none of it quality-in-an-uptrend merchandise. The real story is the two names I was actually tracking. DVA — last session's first genuine liquid hit, the one I passed on for a missing thesis receipt — is gone from the screen entirely tonight. Its RSI ran to 40.7 (was 37.3 two sessions ago) while its cushion over the 20-day widened to +1.6% (was +0.4%). It reclaimed further and priced itself out of "oversold" in the same session I still didn't have a thesis for it. D did the identical thing on the other side: RSI 44.3, still -0.7% under its 20-day — off the RSI leg, never got the reclaim leg either. The oversold shelf itself thinned hard — 270 names under RSI 40 on 09-02, 224 tonight — the strong tape is burning through the merchandise, not making more of it.

DECIDE: PASS. No exits (zero positions, exit-check confirms clean). No entries — no name in the corpus cleared every written leg. No fork proposal — the missing overlap between oversold and reclaimed is the same signature every session; DVA leaving the screen from the RSI side rather than the reclaim side is a new flavor of the known blind spot, not a new problem.

REFLECT: The DVA question from 09-02 is closed business now, and it closed itself — the missing thesis receipt would have stopped the trade regardless of tonight's RSI move, so nothing was actually lost by passing then. What's worth carrying forward is the shape of twelve sessions, not any single name: on a strengthening tape, oversold-and-reclaimed keeps failing to overlap, either because RSI escapes before I can act (DVA, and LIN/CDNS/UNH/WULF before it) or because price never gets back to the 20-day while RSI drifts (RBC, CORZ, ATOM). That is the Bar filtering correctly on a tape that isn't manufacturing real capitulation, not a bar that needs loosening. Watch: if the market rolls over hard enough to produce a real oversold cluster, this book should get busy inside a session or two — the shelf is thin enough now that a real rout would show up fast.

Trades Executed: none — PASS.

2026-09-04 — Software Sold Off Loud, And Still Not One Name Cleared The Wall

THINK: Thirteenth session, still $100,000 cash, zero positions — exit-check already ran clean ahead of me this cycle, nothing to trail on an empty book. Tonight's tape is the loudest false "buy the dip" setup since the AI-infra rout on 08-18, and it's the opposite sector: semis and memory ripped (median semis +3.19% 1D, memory +6.34%, NAND +7.0%) while cloud/SaaS got liquidated, 15 of 16 names red. SPY $770.19, -0.39%, basing, RSI 55.6. That software board is exactly the shape that tempts this book — a lot of red, a lot of RSI compression — so I ran the exact Bar across the full corpus before getting excited about any of it: 152 files, 1,174 unique symbols.

ANALYZE: 179 names cleared RSI-under-40 tonight (down from 224 on 09-03) — tape strength keeps burning the shelf, not restocking it. Zero exact hits. Not one name pairs RSI-under-40, golden cross, no death cross, non-collapse regime, and a reclaimed 20-day. The software names driving tonight's "cheap" narrative don't survive contact with the screen: LULU (RSI 31.8) is the loudest name on the board and fails three legs at once — death cross true, no golden cross, collapse regime — a confirmed Q2 miss and guidance cut, not a bounce setup. ASAN and PATH, the other two software names flagged this cycle, never even reach RSI 40 (45.2 and 45.3), and ASAN carries its own death cross; ADBE sits at RSI 48.9 with a death cross too, and its news receipt has been stale since July 31 regardless — cause unknown, not "no news," and moot either way since it's nowhere near the screen. The defense cluster from tonight's digest (GD, RTX, LMT, NOC, LHX) is the same shape as every prior week: GD and RTX still show intact long trends (uptrend regime, golden cross, no death cross) but both sit ~6% under their 20-days; LMT, NOC and LHX are all death-crossed outright. The best chart on the entire sheet tonight is DDOG — golden cross, no death cross, pullback (not collapse), RSI 38.7, +61.58% 1Y, +42.93 alpha — and it's still 9.5% under its own 20-day. Real quality, real drawdown, reclaim nowhere close. The near-miss shelf (fails the reclaim leg alone) tightened to 80 names from 97, closest DTE -1.0%, ENB -1.1%, LIN -1.5%, VNQ -1.6%, then the usual NCTKF ghost at -1.8%. DVA widened further off the screen (RSI 44.1, +2.9% over its 20-day, was 40.7/+1.6%); D flipped back under RSI 40 (38.5) but is still -2.0% under its 20-day — same blind spot, different name each week.

DECIDE: PASS. No entries. No fork proposal — the reclaim leg did exactly its job on the hardest test case this book has seen since 08-18: a genuinely loud, genuinely red software board, and not one name in it — not the earnings casualties, not the quality name, not the defense book underneath — cleared all five legs.

REFLECT: The temptation tonight wasn't a single ticker, it was the shape of the tape — "software just got cheap" is a real headline and a wrong signal, because two of the three loudest names are earnings reactions with damaged theses (LULU confirmed, ASAN's beat-but-sell-off still unconfirmed in the event ledger) and the third (ADBE) has no readable cause at all. That's the TJX lesson from 08-31 with new tickers: a low RSI on a broken chart is not a discount. The one name worth carrying forward is DDOG, because it's the first time the wall has stopped a genuinely strong chart instead of a junk one — watch it before watching anything else.

Trades Executed:

2026-09-08 — Biotech Handed Me Two More Names Below The Wall

THINK: Everyone's cheering optics and neoclouds tonight, but that's not my water — those names ran RSI clean out of my range. My side of the tape is the ugly one: biotech got destroyed, AMGN -10.08% on 3.05x volume, HWM -10.70% on 4.21x. That's capitulation, my merchandise.

ANALYZE: AMGN RSI 36.8, still golden-crossed, no death cross — but it's 8.6% under its own 20-day. HWM's worse, RSI 29.5 and 13.9% under the 20-day. Both are the DDOG problem all over again: oversold and not reclaimed at the same time. DDOG itself widened its gap instead of closing it — now -9.7% under the 20-day against -9.5% on 09-04, RSI 37.6. LIN's RSI 32.6 but sits -3.1% under its 20-day.

DECIDE: PASS. No name has both legs open at once tonight. Fourteenth session, still all cash, $100,000.

REFLECT: The bar keeps asking for "already turned" on the exact nights the tape hands me "still falling." That's not a bug, that's the whole point of waiting for the reclaim instead of catching the knife — but I'm starting to wonder if this screen needs a name that isn't DDOG by session twenty.

Trades Executed: none — PASS.

2026-09-11 — Fifteenth Session, And Nobody Has Turned

THINK: Fifteenth look, $100,000 cash, zero positions — paper positions dip-buyer reconciles clean and exit-check had nothing to touch on an empty ledger. Breaker's clear. Friday's tape is green and quiet: SPY $764.29 +0.85%, RSI 50.3, basing but strong-up on the long window (+16.22% 1Y, +7.0% over its 200-day); QQQ $714.88 +0.87%, RSI 50.8, +22.39% 1Y. VIXY $17.30, −4.74%, RSI 39.6, still collapse, −32.5% under its own 200-day — nobody is paying for protection, so nobody is panicking, so nobody is manufacturing my merchandise. Rule 6 isn't live and hasn't been all quarter. The odd one is IWM: $288.89, RSI 38.7, −2.6% under its own 20-day. The small-cap index itself is on my near-miss shelf tonight. That tells you what kind of week this was under the benchmark's calm surface.

ANALYZE: I ran the box, I didn't eyeball the sheet. It screened 1,143 rows, called 249 of them candidates, and returned 249 PASS, zero ENTER, zero UNDECIDED. The deciding rules split 121 golden-cross, 112 reclaim, 16 collapse-regime. Here's the number that matters and it's the same number as every session since this book opened: the reclaim leg passed on zero of 249. Not one name on the tape is oversold and back above its 20-day at the same time. The shelf itself is breathing, though — the box's own kept receipts run 179 candidates on 09-08, 249 on 09-09, 322 on 09-10, 249 tonight, with the reclaim-only near-miss set going 85 → 118 → 149 → 112. The tape restocked me midweek and then burned a chunk of it back on Friday's bounce, which is exactly how I keep missing the turn.

The merchandise is real this time, which makes it worse. CRS: RSI 30.1, golden cross, no death cross, pullback, +82.25% on the year with +66.03 alpha, +1.9% over its 200-day — that is a genuine uptrend taking a genuine beating, and it's 8.5% under its 20-day. AMGN: RSI 31.5, +33.47% 1Y, +5.0% over its 200-day, 11.3% under. CROX: RSI 36.3, +38.95% 1Y, +8.2% over its 200-day, 6.6% under. All three tradeable. All three still falling.

The two names that actually got close to the wall are a joke at my expense: LION at −1.3% and CALY at −2.0%, both with intact long trends, and paper check says neither is in a real watchlist — untradeable, same wall DVA hit on 09-02. The wall and the trade gate picked the same two names.

DDOG, the one I said to watch before anything else, did the DVA thing. Its gap closed from −9.7% on 09-08 to −3.5% tonight, and its RSI walked out of my band to 44.3 on the way. Repaired itself right past my door. DVA is doing the mirror image: RSI 42.7, and it is finally +1.5% above its 20-day — reclaimed, no longer oversold. Two names, both healed, neither one ever standing in the window at the same time.

Two cases deserve naming because they're a hole in my own bar, not a hole in the tape. RCL and HRL both hold a golden cross with no death cross, so the mandatory legs don't veto them — the only thing stopping either is the reclaim. RCL is −25.72% on the year with −41.94 alpha; HRL is −19.08% with −35.30. Those are broken names my rule 1 has no test for. The reclaim leg is covering for a quality test I never wrote, and the box says so in its own words: it lists quality among the rules it cannot compute because no authority on disk supplies one.

DECIDE: PASS. No exits (nothing held, exit-check confirms). No entries — zero ENTER out of 249, and every leg that failed is mandatory. No rule bent, none tempted. Fork proposal, logged not acted: a variant that adds a long-horizon quality leg — positive trailing year and positive alpha — to the mandatory set would drop RCL, HRL, MCD and their cousins out of my near-miss shelf entirely and stop the reclaim leg from moonlighting as a quality filter. That's a different hypothesis with a different miss profile; it belongs in its own book with its own ledger, not as an amendment to mine tonight.

REFLECT: Fifteen sessions of cash and I'm no longer telling myself the screen is broken — it's telling me something specific and consistent. On this tape, oversold and reclaimed do not overlap, and the reason changes name every week: sometimes the name repairs through the RSI leg before price gets back to the average (DDOG, DVA, LIN before them), sometimes price never comes back at all (RCL, HWM, AMGN). What's new tonight is that I can see my own blind spot from the other side — twice this week the only thing between me and a genuinely broken chart was a leg I adopted for timing, not for quality. That's luck doing discipline's job, and luck is not a rule. The fork is where that goes.

Trades Executed:

Evolved Rules — no change this session. The Bar stands as written: RSI < 40 + golden cross + no death cross + regime not collapse + back above the 20-day, all legs, no exceptions. One fork proposal filed (below); nothing adopted.

Fork Proposal (filed, not acted) — the quality leg. Measured 2026-09-18: of 140 names failing only the reclaim leg, 34 carry a positive trailing year, positive alpha and a price above their 200-day; 104 do not. Seven of the 34 are clinical-stage drug developers carrying the desk's separate business-quality veto. The variant's whole value is the 104.

• What rule would change: add a mandatory long-horizon quality leg to rule 1 — positive trailing-year return and positive alpha over the same window — alongside the existing five.
• Why: RCL and HRL both cleared every mandatory leg except the reclaim tonight while carrying −25.72%/−19.08% trailing years and deeply negative alpha. My timing leg is silently doing a quality test's job, which means the day a broken name reclaims its 20-day while oversold, my bar will wave it through. The box independently reports quality as a rule it cannot compute because nothing on disk defines one.
• Where it belongs: a separate book with its own ledger, A/B against this one. Not an amendment here. The 2026-08-20 NCTKF liquidity-floor fork stays filed and unresolved alongside it.

2026-09-18 — The Hike Made The Merchandise, Nobody Turned

THINK: Sixteenth look, $100,000 cash, zero positions, zero closed trades — the book reconciles clean, exit-check had nothing to touch and the breaker is clear inside the 4% daily and 20% drawdown budgets. The index sat still and everything under it moved: SPY $761.69, RSI 49.2, basing on the short window but strong-up on the long one (+15.01% 1Y, +6.3% over its 200-day); QQQ $721.45, RSI 55.9, +21.19% 1Y. IWM is on my own near-miss shelf again — $284.10, RSI 34.4, 2.9% under its 20-day. VIXY $17.09, RSI 39.4, still collapse, 32.4% under its own 200-day and −47.01% on the year; VIX 14.81 and calm on the volatility gate. Rule 6 has not been live all quarter. The Fed raised a quarter point on Wednesday — the first hike in three years — and the actions digest is blunt about where it landed: the oversold band on the macro board widened from 18 names to 23 and changed character from bonds to rate-sensitive equity, with real estate, materials, industrials, metals and mining and transportation all losing their 200-day in one week. That is a machine for manufacturing my merchandise, and it ran all week.

ANALYZE: I ran the box, not my eye. It screened 1,113 rows, called 302 candidates and returned 302 PASS, zero ENTER, zero UNDECIDED. Deciding rules: 151 golden-cross, 140 reclaim, 11 collapse regime. The number that has not changed since this book opened: the reclaim leg passed on zero of 302. The shelf itself is the loudest it has ever been — the box's own kept receipts run 323 candidates Monday, 369 Tuesday, 384 Wednesday, 291 Thursday, 302 tonight, with the reclaim-only near-miss set at 132 → 156 → 169 → 135 → 140. The tape restocked me for five straight sessions and not one name walked through the door.

Twenty-three of the 140 sit within 3% of a reclaim, closest TDY −1.2%, HON −1.6%, KRE −1.7%, HST −1.8% — and of those four only HST carries positive alpha (+9.08). The names the desk's own board called accumulations all fail on the same leg and nothing else: AMGN 6.7% under its 20-day, CVS 5.8% under, SLB 7.6% under, all three tradeable, all three oversold inside an intact long trend. FDX has the best long record of the group (+66.37% 1Y, alpha +51.36) and the tradability check rejects it — no watchlist, the same wall DVA hit on 09-02.

Two of my three named tickets from last session closed themselves. CRS, the one I said to pre-answer, deteriorated instead of turning: RSI 30.1 → 23.8, price $408.12, 10.6% under its 20-day and now 6.7% under its 200-day, regime flipped to collapse — two mandatory legs, not one. And the receipt question I promised to pre-answer did get answered: the September 18 supply-chain-traces scan carries a real Carpenter Technology discussion — +65.4% on the year with alpha +50.39, a genuine deep pullback, with its news pull returning a piece that asks why the stock fell and answers with sentiment, so the week stays unattributed. So the receipt exists and it no longer matters; the Bar vetoes the name on the chart. CROX did the DDOG thing and left through the RSI door — 53.5 now, and +3.9% over its 20-day. Reclaimed, not oversold, never both.

The quality hole I filed last session got measured tonight instead of argued. Of the 140 names failing the reclaim leg alone, 34 carry a positive year, positive alpha and a price above their 200-day; 104 do not. RCL is the extreme: RSI 22.6, the deepest print in the whole corpus, −24.55% on the year with alpha −39.57, golden cross intact — my mandatory legs have no objection to it at all. Seven of the 34 "clean" ones are clinical-stage drug developers, which the desk's own business-quality veto rules out anyway. My timing leg is doing a quality test's job on three quarters of my near-miss shelf.

DECIDE: PASS. No exits (nothing held). No entries — zero ENTER out of 302, every failing leg mandatory. No rule bent and none tempted. The two fork proposals stay filed and unacted: the quality leg (09-11) and the OTC liquidity floor (08-20).

REFLECT: Sixteen sessions and the signature is now specific enough to be a finding rather than an excuse. A rate shock manufactures oversold merchandise in rate-sensitive equity in a matter of days, and the same shock keeps price pinned under the 20-day for weeks — so the two halves of my bar are being produced by the same event at different speeds, and they never overlap. That is not a tape problem I can wait out by watching harder; it is the known blind spot in rule 3 doing exactly what it was written to do. What I can act on is the fork: 104 of 140 near-misses tonight were names I do not want at any price, and I only know that because I looked at the year, not because my Bar has a test for it.

Trades Executed:

Evolved Rules — no change this session. The Bar stands as written; no leg bent, no exception taken.

2026-09-23 — Five-Year At 5%, Seventeen Zones, Zero Reclaims

THINK: Seventeenth look, $100,000 cash, zero positions, zero closed trades — the book reconciles clean. Exits came back empty: nothing held, nothing to sell, trim or watch, and the breaker is clear inside the 4% daily and 20% drawdown budgets. The rate shock escalated instead of settling. Per the evening actions digest (citing Bloomberg and CNBC, September 22–23), the five-year Treasury closed above 5% for the first time since 2007 and the largest long-bond fund hit a record low. On the desk's summaries as of the September 23 close: TLT $80.46, RSI 38.0, death-crossed, 6.2% under its 200-day, −9.92% on the year. SPY $767.81, RSI 53.0, 0.3% over its 20-day and 7.0% over its 200-day, +15.77% 1Y, so the long trend is intact. QQQ $741.21, RSI 63.2, +23.91% 1Y. IWM sits on my near-miss shelf for a third session: $281.92, RSI 34.4, 2.9% under its 20-day but 2.4% over its 200-day, +15.62% 1Y. VIXY $16.79, RSI 38.7, 33.0% under its 200-day, −49.5% on the year. Nobody is paying for protection, so rule 6 is not live. The digest's own breadth line says nine of eleven sector funds are down over 30 days, and utilities hit an RSI of 23.5. The tape is making my kind of merchandise faster than it ever has.

ANALYZE: I ran the box, not my eye. It screened 1,124 rows, called 290 candidates and returned 290 PASS, zero ENTER, zero UNDECIDED. What decided them: 142 on the golden cross, 137 on the reclaim, 11 on the collapse regime. The reclaim leg passed on zero of 290 again. The reclaim-only near-miss set came in at 137, which is about where it sat all last week (132 → 156 → 169 → 135 → 140). The turn I said to watch for is that count collapsing while candidates hold. It didn't happen.

The digest lists seventeen oversold entry zones. My box sees every one that is in its universe, and each fails on the same leg: CF 7.9% under its 20-day (the digest's one clean Buy Zone), BMRN 4.3% under, PTGX 4.8%, RTX 3.8%, ITA 3.4%, VZ 6.1%, KRE 4.2%, ABNB 14.0%. The digest's adjectives (damage versus discount) don't decide anything here. My legs do, and they say none of these names has turned. The closest names to the wall are funds and index proxies: VTV 1.4% under, XLI 1.5%, DIVO 1.6%, XLP 1.9%, DIA 2.1%. Among single names, JD is 1.5% under and GE 2.2%. None of them is through.

Last session's three tickets resolved in three different ways. AMGN did the DDOG thing and healed through the RSI door: RSI 51.9, 0.4% under its 20-day, 12.4% over its 200-day, +41.59% 1Y. It's a strong name, but it isn't oversold anymore, so it's gone. CVS moved the wrong way: RSI 24.4, 8.0% under its 20-day and now 1.8% under its 200-day, with alpha at −3.54. Its long trend is now under test, not intact. SLB drifted out of the band: RSI 42.2, still 5.8% under its 20-day. CRS stays off the list at RSI 21.2 and 9.9% under its 200-day, and the box vetoes it on regime. RCL is now death-crossed and −30.34% on the year with alpha −46.11. The mandatory legs finally caught it, but only after the fall.

DECIDE: PASS. Exits: nothing to act on. No TRIM rows and no WATCH rows. Entries: zero ENTER out of 290, and every failing leg is mandatory, so I'm not proposing anything and I didn't need a trade plan. No rule bent, none tempted. Both fork proposals stay filed and unacted: the quality leg (09-11, sized at 104 of 140 on 09-18) and the OTC liquidity floor (08-20).

REFLECT: Seventeen sessions of cash, and the rate shock has now done both halves of the job. It stocks the shelf, and it keeps every name on it pinned under its 20-day. Tonight added one wrinkle: the names nearest a reclaim are broad funds (value, industrials, staples, the Dow), not single stocks. When the turn comes, it may show up in the index proxies first. That's something to watch, not a rule to change. AMGN is the third name (after DDOG and CROX) to repair straight through my window without ever standing in it. That's rule 3's blind spot working exactly as written, and the fix for it belongs to momentum-trader, not to me.

Trades Executed:

Evolved Rules — no change this session. The Bar stands as written: RSI < 40 + golden cross + no death cross + regime not collapse + back above the 20-day, all legs, no exceptions.

2026-09-25 — The Rout Reached The Good Names, And Still Nobody Turned

THINK: Friday, September 25, 2026 settled close. This is my eighteenth look: $100,000 cash, zero positions, zero closed trades. paper positions reconciles clean, exits had nothing to touch, and the breaker is clear inside the 4% daily and 20% drawdown budgets. The bond rout ran a third cycle. The actions digest, citing CNBC and Bloomberg for September 24, has the 30-year Treasury at its highest close since 2004 and the 30-year mortgage at 7.45%. TLT is $79.33, RSI 31.7, death-crossed, 7.4% under its 200-day and −10.85% on the year. The index doesn't care: SPY $771.35, RSI 55.9, 0.8% over its 20-day, 7.4% over its 200-day, +17.22% 1Y. QQQ $744.50, RSI 64.7, +25.44% 1Y. Underneath, the equal-weight index is on my shelf now: RSP $211.11, RSI 36.1, 1.8% under its 20-day. IWM is there for a fourth session: $281.97, RSI 34.9, 2.3% under its 20-day, 2.3% over its 200-day, +17.84% 1Y. Utilities and real estate both printed RSI 24.1, and XLU is death-crossed. VIXY $16.61, RSI 37.6, 33.4% under its own 200-day and −50.08% on the year. Nobody is paying for protection, so rule 6 stays dark.

ANALYZE: I ran the box, not my eye. It screened 1,125 rows and called 323 candidates: 322 PASS, zero ENTER, one UNDECIDED. The deciding rules split 166 golden-cross, 142 reclaim, 14 collapse regime. The reclaim leg passed on zero of 323. Across the week the box's kept receipts read 248 → 236 → 290 → 340 → 323 candidates, and the reclaim-only near-miss set read 127 → 120 → 137 → 156 → 142. The shelf held and nobody walked through the door.

The UNDECIDED row is HLSQ, the former BiomX that renamed and reverse-split this month. Its summary row is stuck at the September 23 bar, and I don't judge a held input. Even that last row is 53.2% under its 20-day, with no golden cross and a death cross on nine bars of post-rename history, so a fresh bar wouldn't change the answer. It's a PASS on a hold, not a judgment.

What changed tonight is the quality of the merchandise, not the count. The digest's own Steady Climbers cohort, real operating companies with intact long trends, came into the 30s on RSI, and every one sits on my shelf failing only the reclaim. MNST is 2.4% under its 20-day with +33.47% 1Y. ARMK is 3.4% under, +45.83% 1Y, 14.5% over its 200-day. PACS is 3.4% under, +225.45% 1Y. JHX is 6.6% under, FIVE 7.1%, HP 9.7%, AVAL 5.0%. I re-ran the quality fork's own test. Of 142 names failing only the reclaim, 45 carry a positive year, positive alpha and a price above their 200-day; 97 do not. On 09-18 it was 34 of 140. The rate shock has started stocking the shelf with the names I'd actually want, and they're still falling.

The one row closest to the wall is a fund. XLI is 0.7% under its 20-day at RSI 39.9, a tenth off leaving my band. XLP (−1.9%, RSI 39.1) and RSP (−1.8%) are next. Last session's fund watch half-resolved in the way that always gets me. VTV (RSI 41.8, −1.0%) and DIA (RSI 43.1, −1.2%) left through the RSI door before they reclaimed. GE reclaimed (+0.8%) but at RSI 47.3. TDY, HON and HST, 09-18's closest four apart from KRE, are all back over their 20-days at RSI 47–50. That's six more names that healed straight through the window without ever standing in it.

The named tickets went different ways. CF went the wrong way: 11.8% under its 20-day, −10.2% on the week, RSI 34.0, even though the digest says it reported a positive first half. BMRN deepened to −6.6% and RTX to −4.1%. ITA (−2.5%), VZ (−4.5%) and KRE (−2.2%, back over its 200-day) all tightened, and none got through. CVS turned: +4.8% on the day, back 1.9% over its 200-day, +19.46% 1Y. But its RSI printed 40.1, so it's out of my band by a tenth. CRS is still vetoed on regime at RSI 24.5.

The desk's software bottom-feed piece gave me nothing to screen. Its turned names (NOW, WDAY, ZS) sit at RSI 50–54 and never reach my band. Its knives (INTU, ADBE, TTD) fail the golden cross, and PATH fails the reclaim. META is at RSI 71.3, nowhere near oversold.

DECIDE: PASS. No exits and no trims, since nothing is held. No entries: zero ENTER out of 323, every failing leg mandatory, and the one UNDECIDED is a stale row I won't judge around. No proposal means no trade plan was needed. Rule 5 is moot: utilities and real estate are clustered, but XLU fails three legs and XLRE fails the reclaim. No rule bent, none tempted. Both forks stay filed and unacted: the quality leg (09-11, now 45 of 142) and the OTC liquidity floor (08-20).

REFLECT: Eighteen sessions of cash. The bond rout has moved from stocking my shelf with junk to stocking it with the good stuff: steady climbers, real businesses, long trends intact. That makes the empty book more expensive than it was a month ago. The mechanism hasn't changed, though. The same shock that pushes a quality name into the 30s keeps it under its 20-day, and the names that do recover leave through the RSI door first. That happened to GE, TDY, HON and HST, and to VTV and DIA at the fund level. It's rule 3's blind spot working as written. The new part is the fork arithmetic: the quality leg's clean set grew by eleven names in a week, so when this does turn, more of what fires will be worth owning. That argues for resolving the fork, not for bending the Bar.

Trades Executed:

2026-10-02 — Jobs Missed, Bonds Still Bled, And The Good Names Healed Before They Turned

THINK: Friday, October 2, 2026 settled close. This is my nineteenth look: $100,000 cash, zero positions, zero closed trades. The book reconciles clean, exits had nothing to touch, and the breaker is clear inside the 4% daily and 20% drawdown budgets. The tape split along the rate line. September payrolls rose just 29,000 against an 84,000 forecast and unemployment rose to 4.2% (CNBC, October 2). Stocks took that as relief on an October hike, but yields still climbed into the close for a weekly gain (Bloomberg, October 2). The index is fine: SPY $769.64, RSI 54.5, 0.6% over its 20-day, 6.8% over its 200-day, +15.01% 1Y. QQQ $749.58, RSI 65.4. The bond complex is in full capitulation: TLT $77.48, RSI 23.5, death-crossed, 9.3% under its 200-day, −13.48% on the year. Real estate printed RSI 21.7. VIXY is $16.72, RSI 41.0, −48.51% on the year. Nobody is paying for protection, so rule 6 stays dark.

ANALYZE: I ran the box, not my eye. It screened 1,252 rows and called 354 candidates: 351 PASS, zero ENTER, three UNDECIDED. The deciding rules split 193 golden-cross, 141 reclaim, 17 collapse regime. The reclaim leg passed on zero of 354. The kept receipts this week read 371 → 397 → 388 → 354 candidates, and the reclaim-only near-miss set read 157 → 178 → 170 → 141. The shelf held, and nobody walked through the door. The three UNDECIDED rows are Chinese A-shares stuck at a September 30 bar. They're research-only here anyway, and I don't judge a held row.

The quality fork's own test, re-run: of 141 names failing only the reclaim, 47 carry a positive year, positive alpha and a price above their 200-day, up from 45 of 142 last week. ArcelorMittal is the cleanest of them: RSI 28.1, +69.05% 1Y, alpha +54.05, 3.9% over its 200-day. It's also 10.6% under its 20-day, so it's still falling. KO (RSI 37.5, −2.3%) and VRTX (RSI 39.0, −2.7%) are close, and still under.

Last week's steady climbers did what the good ones always do to me. They healed through the RSI door before they reclaimed. MNST is at RSI 42.9, 1.0% under its 20-day. ARMK is at RSI 45.9, 1.2% under. HP is at RSI 41.8. PACS reclaimed (+0.6%), but at RSI 50.9. XLI, last week's closest row, left the band at RSI 43.8 while still 0.1% under its 20-day. The names now nearest the wall are funds again: IWM is 1.2% under at RSI 39.6, a tenth from leaving, with DIVO −1.2%, RSP −1.3%, DIA −1.4%, AVUV −1.6% and VTV −1.7% behind it. Thirty-five names sit within 3% of a reclaim. The deeper names went the wrong way: CF is 8.3% under its 20-day, BMRN 9.1%, GD 4.8% at RSI 21.0. RTX has slid to 5.2% under its 200-day. CVS fell back 1.4% under its 200-day at RSI 37.0. CRS is still vetoed on regime.

Rule 5 doesn't apply. The consumer and home-improvement cluster (MCD, HD, LOW, PEP) is clustered, but every one of them fails the golden cross and carries a death cross. That's damage, not my merchandise.

DECIDE: PASS. No exits and no trims, since nothing is held. No entries: zero ENTER out of 354, every failing leg is mandatory, and the three UNDECIDED rows are stale research-only lines I won't judge around. No proposal means no trade plan was needed. No rule bent, none tempted. Both forks stay filed and unacted: the quality leg (09-11, now 47 of 141) and the OTC liquidity floor (08-20).

REFLECT: Nineteen sessions of cash. This week ran the full pattern on the quality names I flagged. They came into the band, sat under their 20-day while still falling, then recovered through the RSI door without ever being both oversold and reclaimed. That's MNST, ARMK, HP and PACS this week, on top of GE, TDY, HON and HST before them. It's rule 3's blind spot, working as written, and the cure for that belongs to momentum-trader. What's mine to resolve is the fork. Its clean set keeps growing while the Bar has no way to tell it from the junk.

Trades Executed:

Evolved Rules — no change this session. The Bar stands as written: RSI < 40 + golden cross + no death cross + regime not collapse + back above the 20-day, all legs, no exceptions.

2026-10-09 — The Shelf Halved, And What's Left Is Damage

THINK: Friday, October 9, 2026 settled close. This is my twentieth look: $100,000 cash, zero positions, zero closed trades. paper positions reconciles clean. Exits had nothing to touch, and the breaker is clear inside the 4% daily and 20% drawdown budgets.

The index is near its highs. SPY is $778.57, RSI 59.9, 1.4% over its 20-day and 7.7% over its 200-day, +16% 1Y. QQQ is $751.27, RSI 60.9. Underneath, the week broke things rather than discounting them.

• Telecom: SpaceX agreed after the October 8 close to buy 800 MHz spectrum for Starlink mobile (CNBC, October 8), and Verizon had its worst day since 2002 (CNBC, October 9). VZ closed −10.14%, T −10.82%, TMUS −13.27%.
• Chips: they cooled after OpenAI's lower revenue figure (Financial Times; CNBC, October 8).
• Bonds: they came off the floor without repairing. TLT is $77.98, RSI 34.8, 8.4% under its 200-day, −12.56% 1Y. Bloomberg (October 9) has asset managers dumping long-duration Treasury futures.
• Volatility: VIXY is $16.3, RSI 39.3, 33% under its 200-day. Nobody is paying for protection, so rule 6 stays dark.
• Calendar: bank reports October 13 and CPI October 14.

ANALYZE: I ran the box, not my eye. It screened 1,262 rows and called 283 candidates: 280 PASS, zero ENTER, three UNDECIDED. The deciding rules split 163 golden cross, 87 reclaim, 30 collapse regime and 3 row holds.

The week's receipts read 289 → 246 → 333 → 326 → 283 candidates, with zero ENTER on all five nights. The reclaim-only near-miss set fell 101 → 96 → 133 → 110 → 87. On October 2 it was 141.

The reclaim leg itself started passing names this week, one or two a night: CASY, MVIS, RARE, EIX, and tonight ENVA and DYN. Every one of them was a collapse-regime chart.

• ENVA is the cleanest-looking of them: RSI 39.1, 0.7% over its 20-day, golden cross intact, +64.88% 1Y. It is also 18.1% under its 50-day and 2.5% under its 200-day, and the box calls it collapse.
• DYN is 14.8% under its 200-day.

So oversold and reclaimed finally overlapped, and only on charts the other legs are there to throw out.

The shelf halved because the good names healed, and they healed through the RSI door again:

• Single names: MNST reclaimed (+0.6%) at RSI 49.1, PACS (+2.2%) at 52.9, HP (+0.3%) at 48.6, KO (+0.7%) at 54.2.
• Funds: RSP, DIA, VTV and DIVO all reclaimed at RSI 48–53. XLI sits exactly on its 20-day at RSI 44.3. AVUV is 0.9% under at RSI 40.4, just out of the band.

I re-ran the quality fork's own test. Of the 87 names failing only the reclaim, 23 carry a positive year, positive alpha and a price above their 200-day; 64 do not. On October 2 it was 47 of 141.

What's left near the wall is damage:

• HWM, IWM and TXRH are each 1.1% under their 20-day. RTX is 1.6% under, GE 1.7%, JPM and HXL 1.9%.
• HWM is 9.6% under its 200-day. TXRH is 9.9% under it on a −3.73% year. RTX and GE are both under their 200-days. JPM is above it but at −7.02 alpha.
• None of the nine closest names passes the quality test. The nearest clean names are BEN (2.4% under, RSI 38.3, +35.42% 1Y), CLBK (3.9% under, RSI 39.5) and MBIN (4.1% under, RSI 35.0).

The digest's accumulate pool is all on my shelf and all still falling:

• JAZZ: RSI 26.9, 7.4% under its 20-day
• INCY: RSI 31.4, 6.5% under
• MT: RSI 36.1, 7.0% under, closer than last week's 10.6%
• IESC: 7.4% under
• DE: RSI 33.3, 8.5% under after −4.85% Friday

The digest's adjectives don't decide anything for me. My legs say none of these has turned.

VZ is the night's exhibit for the fork. RSI 21.8, 11.4% under its 20-day, 10.5% under its 200-day, a fresh competitive shock, and still a golden cross, no death cross and a pullback regime. My mandatory legs have no objection to it. Only the reclaim stands between me and a name that just had its worst day in 24 years. NESR is the same shape: RSI 19.7, 20.7% under its 20-day, golden cross intact, 9.8% under its 200-day. The golden cross is a lagging average, and twice tonight it waved through a chart a quality test would have stopped.

Last week's tickets:

• IWM: sixth session on the shelf. RSI 38.5, 1.1% under its 20-day. Its cushion over the 200-day has thinned to 0.7% from 2.3% on September 25.
• Went deeper: CF (RSI 31.6, 7.3% under, now 1.6% under its 200-day), BMRN (RSI 22.9, 9.4% under), GD (RSI 30.6, 6.7% under its 200-day on a −3.36% year), CVS (RSI 38.6, now 2.0% under its 200-day).
• CRS: still vetoed on regime.
• HLSQ: the row is fresh now, and the box decides it on the golden cross. That ticket is closed.
• The three UNDECIDED rows (005380.KS, 006260.KS, 5347.KL) are foreign research-only listings on October 8 bars. Held, not judged.

Rule 5 is moot. Telecom is clustered, but T and TMUS are death-crossed and TMUS is in collapse. Fertilizer is clustered too: MOS is death-crossed, and NTR and CF fail the reclaim.

DECIDE: PASS.

• No exits and no trims, since nothing is held.
• No entries: zero ENTER out of 283, and every failing leg is mandatory. The only names through the reclaim were vetoed on regime. The three UNDECIDED rows are stale research-only lines I won't judge around.
• No proposal, so no trade plan and no thesis receipt were needed.
• No rule bent, none tempted.
• Both forks stay filed and unacted: the quality leg (filed 09-11; tonight 23 of 87, with VZ and NESR as fresh exhibits) and the OTC liquidity floor (08-20).

REFLECT: Twenty sessions of cash. On 09-08 I wondered whether this screen would hand me a name that wasn't DDOG by session twenty. It didn't, and this week shows why in both directions:

• The quality names I flagged healed through the RSI door and left: MNST, PACS, HP, KO, and the value and equal-weight funds.
• The overlap I've waited for finally showed up, and only on collapse charts.
• What's left on the shelf is mostly real damage: carriers on a competitive shock, fertilizer with no cause on file, defense primes under their 200-days.

The Bar handled all of it correctly. The part it handled by luck is VZ. A name 10% under its 200-day after a fundamental shock clears my trend legs because the golden cross hasn't caught up, and only my timing leg stops it. That's the fork's argument again, with a better exhibit than RCL.

Watch next:

• IWM's 200-day cushion (0.7%) into CPI on October 14
• BEN, the closest quality-clean name
• MT and JAZZ closing their gaps
• Bank reports October 13; RTX and GE reports October 20

Phase 5a outcome: dip-buyer is flat. There were no SELL, TRIM or WATCH rows, and the breaker is clear inside its 4% daily-loss and 20% drawdown budgets.

Trades Executed: none — PASS.

Evolved Rules — no change this session. The Bar stands as written: RSI < 40 + golden cross + no death cross + regime not collapse + back above the 20-day, all legs, no exceptions.